San Diego, California, United States The venture was found in North America in United States. The main office of represented VC is situated in the San Diego.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Inglewood Ventures, startups are often financed by Sanderling Ventures, Life Sciences Partners, Biofrontier Partners. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Life Sciences Partners, GeneChem. In the next rounds fund is usually obtained by Sanderling Ventures, Bioventures Investors, Mitsui Global Investment.
This Inglewood Ventures works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Inglewood Ventures the average startup value is 100-500 millions dollars. The increased amount of exits for fund were in 2008. The important activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cylene Pharmaceuticals, Genicon Sciences, GeneFormatics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Arena Capital Partners | New York, New York, United States |
| Atom Factory | California, Culver City, United States |
| Density Ventures | Canada, Ontario, Toronto |
| East Chain Co. | Cayman Islands, Midland |
| Edenred Capital Partners | England, London, United Kingdom |
| Eir Partners | - |
| FINANCIERE FONDS PRIVES | France, Ile-de-France, Paris |
| Fucheng Touzi | China, Guangdong Province, Guangzhou City |
| Hinsdale | Durham, North Carolina, United States |
| Hongshi Capital Management | Beijing, Beijing, China |
| Pendrell Corporation | Kirkland, United States, Washington |
| Redmile Group | California, San Francisco, United States |
| SAT Capital | - |
| Shenzhen Qianhai Wanrong Hongtu Investment Fund | China, Guangdong, Shenzhen |
| Techpeaks | Italy, Trentino-Alto Adige, Trento |
| Tennessee Angel Fund | - |
| Western Union Accelerator Powered by Techstars | Colorado, Denver, United States |
| Windcrest Partners | New York, New York, United States |
| Zhangjiagang Dagangcheng | China, Jiangsu, Zhangjiagang |
| Zhengu | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 18 Sep 2003 | San Diego, California, United States | |||
Cylene Pharmaceuticals | $3M | 17 Oct 2001 | San Diego, California, United States | ||
NewBiotics | $11M | 25 Jul 2001 | San Diego, California, United States | ||
CardioNet | $6M | 01 May 2000 | Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 18 Sep 2003 | San Diego, California, United States | |||
Cylene Pharmaceuticals | $3M | 17 Oct 2001 | San Diego, California, United States | ||
NewBiotics | $11M | 25 Jul 2001 | San Diego, California, United States | ||
CardioNet | $6M | 01 May 2000 | Pennsylvania, United States |
